Resmed (RMD) Shares Outstanding (Diluted Average) (2009 - 2026)

Resmed has reported Shares Outstanding (Diluted Average) for 10 years, with the latest figure at $145.7 million in Q1 2026.

• For the quarter ending Q1 2026, Shares Outstanding (Diluted Average) fell 1.02% year-over-year to $145.7 million; the trailing twelve-month figure through Mar 2026 stood at $145.7 million (down 1.02% YoY), and the FY2025 full-year result was $147.3 million, changed 0.14% from the prior year.
• Shares Outstanding (Diluted Average) for Q1 2026 stood at $145.7 million, roughly flat from $146.4 million in the prior quarter.
• The five-year high for Shares Outstanding (Diluted Average) was $147.6 million in Q3 2024, with the low at $145.7 million in Q1 2026.
• Historically, Shares Outstanding (Diluted Average) has averaged $147.2 million across 5 years, with a median of $147.4 million in 2022.
• Annual changes were most pronounced in 2022 — Shares Outstanding (Diluted Average) increased 0.4% — and 2026, when it decreased 1.02%.
• Resmed's Shares Outstanding (Diluted Average) stood at $147.4 million in 2022, then grew by 0.12% to $147.5 million in 2023, then dropped by 0.02% to $147.5 million in 2024, then slipped by 0.78% to $146.4 million in 2025, then dropped by 0.44% to $145.7 million in 2026.
• The last three Shares Outstanding (Diluted Average) figures came in at $145.7 million (Q1 2026), $146.4 million (Q4 2025), and $146.9 million (Q3 2025), per Business Quant data.